Lomir Tablet 2.5 mg is a calcium channel blocker used primarily to treat hypertension (high blood pressure) and chronic stable angina. It works by relaxing blood vessels and reducing the workload on the heart.
Lomir Tablet 2.5 mg is used for:
| Brand Name | Lomir |
|---|---|
| Type | Tablet |
| Weight | 2.5 mg |
| Generic | Isradipine |
| Manufacturer | Novartis (Bangladesh) Ltd. |
| Available in | English বাংলা |
Lomir Tablet 2.5 mg works by blocking calcium channels in the smooth muscle cells of blood vessels. This prevents calcium from entering the cells, which leads to relaxation and dilation of the blood vessels. This reduction in vascular resistance decreases blood pressure and reduces the heart's workload.
The antihypertensive effects of isradipine can be observed within 1 to 2 hours after administration, with peak effects typically occurring within 6 to 8 hours. Full therapeutic effects for blood pressure control may take a few weeks of consistent use.
Lomir Tablet 2.5 mg is well absorbed from the gastrointestinal tract. It undergoes extensive first-pass metabolism in the liver, which affects its bioavailability. The oral bioavailability is approximately 10-20%.
Lomir Tablet 2.5 mg is primarily metabolized in the liver. The drug and its metabolites are excreted mainly via the feces, with a smaller amount excreted in the urine.
The typical dosage for isradipine is:
Always follow the specific dosing instructions provided by a healthcare professional.
Lomir Tablet 2.5 mg is administered orally, typically in the form of tablets. It should be taken with or without food, and it's important to take the medication at the same times each day to maintain even levels in the bloodstream.
Common side effects include:
Serious side effects are rare but may include severe hypotension, worsening angina, or allergic reactions. Contact a healthcare provider if severe or persistent symptoms occur.
Symptoms of toxicity may include severe hypotension, bradycardia (slow heart rate), or syncope (fainting). In cases of overdose, seek immediate medical attention. Supportive measures and symptomatic treatment may be necessary.
There are no specific food interactions with isradipine, but it should be taken consistently in relation to food intake to maintain stable drug levels.
Lomir Tablet 2.5 mg is classified as a Category C drug during pregnancy, meaning that risk to the fetus cannot be ruled out. It should be used only if the potential benefits justify the potential risks. Consult a healthcare provider if pregnant or planning to become pregnant.
It is not known if isradipine is excreted in breast milk. Use during lactation should be approached with caution, and a healthcare provider should be consulted to evaluate the risks and benefits.
In case of acute overdose, symptoms may include severe hypotension, bradycardia, or dizziness. Immediate medical attention is required. Treatment is generally supportive, with measures to stabilize blood pressure and heart rate.
The volume of distribution for isradipine is approximately 1.7 L/kg, indicating its distribution throughout the body, including the cardiovascular tissues.
The elimination half-life of isradipine is approximately 2 to 4 hours, allowing for twice-daily dosing to maintain effective blood levels.
Lomir Tablet 2.5 mg is primarily cleared through hepatic metabolism. The drug’s clearance rate may be affected by liver function, and dose adjustments may be necessary in patients with liver impairment.
See in details version Lomir Tablet 2.5 mg also Lomir Tablet 2.5 mg in bangla